Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TOP2A inhibition by temozolomide and its predictive value of GBM patients survival

TOP2A inhibition by temozolomide and its predictive value of GBM patients survival

US Patent 9487818 · Granted Nov 8, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers2018
Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers2018
Nicotinamide phosphoribosyltransferase (NMPRTase) inhibitor for glioma therapy2016
Methods and kits useful for the identification of astrocytoma, it's grades and g2014
Methods and kits useful for the identification of astrocytoma, it's grades and g2014
Method for diagnosis of glioma: distinguishing between progressive and de novo t2010
Method for diagnosis of glioma: distinguishing between progressive and de novo t2010